Objectives Psychopathy-related traits, especially those tapping the 'emotional dysfunction' aspect of psychopathy that is characterized by lack of emotional responsiveness, are thought to be of genetic origin, but molecular genetic studies are yet to be undertaken. Gene variants that affect COMT, MAOA and 5HTT activity have previously been linked to antisocial behaviour. The aims of this study were to test whether these gene variants are linked to psychopathy traits in attention-deficit hyperactivity disorder (ADHD).
Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity Objectives Psychopathy-related traits, especially those tapping the 'emotional dysfunction' aspect of psychopathy that is characterized by lack of emotional responsiveness, are thought to be of genetic origin, but molecular genetic studies are yet to be undertaken. Gene variants that affect COMT, MAOA and 5HTT activity have previously been linked to antisocial behaviour. The aims of this study were to test whether these gene variants are linked to psychopathy traits in attention-deficit hyperactivity disorder (ADHD).
Methods Adolescents were followed up 5 years after an initial diagnosis of ADHD. Psychopathy trait scores were assessed [total scores and 'emotional dysfunction' (also referred to as 'affective') scores] and the MAOA 30-bp variable number of tandem repeats, SLC6A4 44-bp insertion/deletion and COMT Val158Met variants were genotyped.
Introduction
Psychopathy is thought to be a personality dysfunction that is strongly neurobiological in its origins (Blair et al., 2006) . Twin studies have indeed shown that there are substantial genetic influences on psychopathy trait measures (Viding et al., 2005; Larsson et al., 2006; Baker et al., 2007; Viding et al., 2007) , but the molecular genetic basis has not yet been investigated. This is despite increasing molecular genetics research into the related construct of antisocial behaviour (Moffitt and Scott, 2008) .
In adults and adolescents, the emotional dysfunction observed in psychopathy, which is characterized by a lack of emotional responsiveness, has been termed the 'affective' component (Forth et al., 2003; Hare, 2003; Johnstone and Cooke, 2004) . However, to avoid confusion caused by connotations of this term, specifically that there is a relationship with affective disorders, we have instead used the expression 'emotional dysfunction'. In children, a similar concept of 'callous-unemotional traits' has also been developed. (Frick et al., 1994; Christian et al., 1997; Frick and Ellis, 1999) . Although the concordance is not perfect between these constructs, they both include features such as callousness and a lack of remorse or affect and are characterized by lower emotional responsiveness (Murrie and Cornell, 2002; Johnstone and Cooke, 2004; Lee et al., 2004) .
It has been considered that 'emotional dysfunction' or the related construct of callous-unemotional traits taps the most biologically distinctive aspect of psychopathy (Murrie and Cornell, 2002; Lee et al., 2004) . These constructs have also been found to be heritable (Viding et al., 2007) . The different components of psychopathy seem to be primarily explained by a common genetic factor (Larsson et al., 2006) but with some specific genetic influences. Thus, any investigation of risk factors associated with psychopathy should examine not only global measures of psychopathy, but also the 'emotional dysfunction' aspect of psychopathy.
Although psychopathy trait scores show a strong association with conduct disorder (CD), there has been much interest in the possibility that psychopathy traits, especially the 'emotional dysfunction' or callous-unemotional traits index a different clinical construct from CD and have a distinct underlying biology (Blair, 2003; Blair et al., 2006) . A recent series of twin studies, however, show that most of the overlap between CD symptoms and psychopathy (Baker et al., 2007; Larsson et al., 2007) as well as callous-unemotional traits (Viding et al., 2007) is attributable to a shared genetic aetiology. Nevertheless, these studies also showed some specific genetic influences, albeit smaller effects, on conduct problems and psychopathy.
Overall, these twin studies suggest that there will be some overlap in genetic risk factors for CD symptoms and psychopathy traits and similarly for the different components of psychopathy but that the genetic overlap will not be complete.
Animal and human studies suggest that serotonin and dopamine pathways play a key role in regulating aggression and emotional response (Volavka et al., 2004; Drabant et al., 2006; Heinz and Smolka, 2006; Nelson and Trainor, 2007) . The serotonin pathway may also play an important role in psychopathy, although so far there has been little research on the contribution of specific neurotransmitters to the development of psychopathy (Glenn and Raine, 2008 ).
However, molecular genetic studies can potentially provide some insight into the involvement of specific biological pathways. In support of the premise that dopamine and serotonin may be important in psychopathy and related behaviours, gene variants affecting activity of the serotonin transporter (5HTT) and the two degradation enzymes, monoamine oxidase A (MAOA) and catechol-O-methyltransferase (COMT) have been linked to antisocial behaviour (Thapar et al., 2005; Craig, 2007; Caspi et al., 2008) and with functioning of the amygdala and prefrontal cortex (PFC) (Raine, 2002; Blair, 2003; Pezawas et al., 2005; Smolka et al., 2005; Meyer-Lindenberg et al., 2006) that are brain regions implicated in psychopathy. However, the molecular genetic basis of psychopathy traits has not been examined previously.
Children with attention-deficit hyperactivity disorder (ADHD) show especially increased levels of antisocial behaviour and CD and this comorbidity seems to index genetic as well as clinical heterogeneity (Thapar et al., 2001; Thapar et al., 2005; Caspi et al., 2008) . Individuals with ADHD are also considered to be a high-risk group for elevated levels of psychopathy traits and have indeed been termed 'fledgling psychopaths' (Lynam, 1996) . Investigation of the sample used in this study, showed that children with ADHD show elevated levels of total psychopathy and emotional dysfunction trait scores in comparison with a UK adolescent normative sample (Fowler et al., 2009) . This supports the premise that individuals with ADHD are a high-risk group for showing elevated levels of psychopathy traits.
In this study, we set out to examine whether gene variants that affect COMT, MAOA and 5HTT activity and that have been earlier linked to antisocial behaviour are associated with psychopathy traits in ADHD.
Methods

Participants and measures
Individuals included in this study were selected from a larger genetic study of ADHD. They had originally been recruited from Child and Adolescent Mental Health Clinics in the UK for the purpose of the original ADHD study 5 years ago (Thapar et al., 2005) . Individuals were selected for this study on psychopathy, if they were currently (5 years after the original study assessment) aged 12 years or above.
At 5-year follow-up, 197 individuals were eligible to participate, of whom 156 (79%) agreed to take part in this study on psychopathy. Psychopathy scores were successfully collected for 147 (75%) individuals, as some individuals did not complete all measures at follow-up. All of these individuals could not be genotyped for all of the variants and this is further explained in the Genetic data section.
Individuals at the time of initial recruitment to the larger genetic study of ADHD all met Diagnostic and Statistical Manual of Mental Disorders (DSM)-III-R or DSM-IV diagnostic criteria for ADHD and had IQ scores of above 70. Individuals with Tourette's syndrome, pervasive developmental disorder or a neurological condition were excluded. All the families were of UK White origin (both parents and grandparents). A full description of the sample and measures is provided elsewhere (Thapar et al., 2005; Fowler et al., 2009 ).
At follow-up, the parent version of the Child and Adolescent Psychiatric Assessment (Angold et al., 1995b) was used to assess clinical symptoms of key DSM-IV disorders, including ADHD, oppositional defiant disorder and CD at both time points. The child version of the Child and Adolescent Psychiatric Assessment provided additional information on psychopathology in adolescence (Angold and Costello, 1995a; Angold et al., 1995b) . Symptoms and impairment in school were assessed using the Child ADHD Teacher Telephone Interview (Holmes et al., 2004) . Psychopathy traits were assessed at follow-up in adolescence using the Hare Psychopathy Checklist-Youth Version (PCL-YV) (Forth et al., 2003) . Total psychopathy scores and an 'emotional dysfunction' component (referred to as the 'affective' score in the PCL-YV) were calculated from this measure using the method described by Forth et al., 2003 . As part of the development of the PCL-YV, extensive validation and checking of reliability of these measures has been undertaken by Forth et al., 2003 in numerous clinical and community samples. Owing to a positive skew, total and 'emotional dysfunction' scores were natural log transformed. The study was approved by the North-West England Multi-Centre Research Ethics Committee, UK, and written informed consent and assent was obtained from parents and children.
Genetic data
Genotype had been completed using standard laboratory techniques as part of the original larger genetic study of ADHD. Although some genotyping data existed for all 147 individuals, because of the ongoing nature of the original study (Thapar et al., 2005) genotypic information was not available on all individuals for all genotypes. Individuals had either not yet been recruited to the study at the time of genotyping a particular variant or the individual had been recruited at the start of the study and no remaining DNA existed when genotyping was undertaken.
Genotyping data were available on 88 individuals for the MAOA variant, 89 for the 5HTT variant and 99 for the COMT variant. Genotypes/alleles were coded a priori based on functional activity and association with risk of aggressive/antisocial behaviour (Caspi et al., 2002; Retz et al., 2004; Thapar et al., 2005 
Results
Complete follow-up clinical data were available for 147 individuals (136 males), aged 12-19 years (mean 14.5 years, SD 1.7). There were no significant differences (P=0.16-0.61), in baseline ADHD and CD symptom scores, full scale IQ or socio-economic status, between individuals with and without measures of psychopathic traits or those with complete and incomplete genotypic data.
The average total and 'emotional dysfunction' psychopathy scores were 5.91 (SD=4.21, range 0-19) and 1.00 (SD=1.29, range 0-6), respectively. The results of the genetic analysis are shown in Table 1 . Those individuals possessing a low-activity MAOA allele and those homozygous for the low-activity 5HTT allele showed significantly higher total and 'emotional dysfunction' psychopathy scores. The high-activity COMT Val/Val genotype was associated with significantly higher 'emotional dysfunction' psychopathy scores but not total psychopathy scores. Effect sizes for each variant are provided in Table 2 (Cohen, 1988) . Each variant has a small effect size. When associated variants were considered together by adding them simultaneously to the regression analysis, the estimated effect sizes were 0.16 for total psychopathy and 0.56 for 'emotional dysfunction' scores. We next tested whether the genetic associations (5HTT and MAOA variants) with total psychopathy scores were attributable to the 'emotional dysfunction' component. When controlling for 'emotional dysfunction' scores, the associations between total psychopathy scores and the 5HTT variant (b=0.08 P=0.35) and MAOA variants (b=0.08, P=0.33) became nonsignificant suggesting that these associations with total psychopathy scores were, in fact, driven by 'emotional dysfunction' scores. Controlling for age at assessment, sex (COMT and 5-HTT only), and use of stimulant medication (no covariate was significantly associated with any of the outcomes). *P < 0.05. **P < 0.01. (Cohen, 1988) .
The results were the same, that is, these genetic findings for the total psychopathy scores seemed to be explained by the 'emotional dysfunction' component, when we used the alternative method of testing for association with psychopathy scores where the 'emotional dysfunction' component was subtracted from the total score (results available from corresponding author).
None of the genetic associations were explained by the presence of concurrent DSM-IV CD or ADHD symptom severity.
We have earlier found association of the COMT Val/Val genotype with childhood-onset CD symptoms in a larger baseline sample (Thapar et al., 2005) from which this current sample was drawn (Fowler et al., 2009 ) and those findings have since been replicated (Caspi et al., 2008) . This association with CD symptoms was still present in the smaller follow-up subsample (b=0.20, t=1.95, P=0.05). When testing whether early onset CD symptom severity explained the relationship between COMT and the 'emotional dysfunction' psychopathy scores, it was found to only partially explain the association (accounting for 23% of the relationship).
Finally, although we defined our risk genotypes a priori on the basis of earlier evidence to avoid multiple testing, as there is not complete certainty as to whether risk is additive across alleles for each of these variants, for descriptive purposes we also provide mean total and 'emotional dysfunction' psychopathy scores for each of the three genotypes for the COMT and 5HTT variants in Table 3 (as MAOA is on the X chromosome and only men were analysed, this was not necessary for this variant).
Discussion
Findings from this study
In this study of adolescents with childhood ADHD, we show that variants in genes encoding the 5HTT and the two degradation enzymes, MAOA and COMT are associated with the 'emotional dysfunction' component of psychopathy traits. These gene variants were selected because they have earlier been implicated in antisocial and aggressive behaviour in humans (Retz et al., 2004; Volavka et al., 2004; Craig, 2007) and other primates (Ferrari et al., 2005) but some molecular genetic findings have been found to be inconsistent. There are many possible explanations for this amongst which are the presence of gene-environment interaction (Caspi et al., 2002) , genetic and clinical heterogeneity and falsepositive and negative findings. Another potential reason is that there could be a stronger link with a specific phenotypic aspect of antisocial behaviour. Psychopathy traits, especially 'emotional dysfunction' characteristics may accompany some, but not all, antisocial behaviour. Indeed, in this study, we found no evidence that these variants were associated with concurrent ADHD severity or CD symptoms; instead, the link was with 'emotional dysfunction' scores.
Twin studies suggest that there are both shared and distinct genetic influences on psychopathy traits and CD symptoms. Our molecular genetic findings on psychopathy trait scores in ADHD are consistent with these findings. There are genetic variants that are associated with psychopathy traits independent of a relationship with childhood CD symptoms although there is some overlap. Specifically, we find the COMT Val/Val genotype is associated with both childhood CD symptoms and 'emotional dysfunction' psychopathy scores, whereas the 5HTT and MAOA variants influence 'emotional dysfunction' scores and not CD symptoms.
Although we also find an overlap in genetic aetiology between total psychopathy scores and 'emotional dysfunction' scores, in that both show association with the 5HTT and MAOA variants, the genetic association with total psychopathy scores seems to be driven by 'emotional dysfunction' traits. This suggests that distinguishing 'emotional dysfunction' traits may be useful from a genetics perspective.
Links between MAOA, 5HTT, COMT and antisocial behaviour
MAOA is an enzyme that is especially important for degradation of 5HT. It also metabolizes dopamine and noradrenaline. There has been considerable interest in the putative role of variation in this gene and links with antisocial behaviour. First, MAOA knockout mice that have lost MAOA gene function show increased 5HT levels and aggressive behaviour (Cases et al., 1995) . Second, a Dutch family with an MAOA gene mutation showed links with Controlling for age at assessment, sex and use of stimulant medication. *P < 0.05.
violent behaviour (Brunner et al., 1993) . After this, there have been a number of published studies on links between this functional polymorphism in the MAOA gene (30-bp promoter region VNTR) that is associated with changes in transcriptional activity of this gene and antisocial behaviour (Volavka et al., 2004; Craig, 2007) . In general, it has been the low-activity alleles that have been found to be associated with antisocial, violent and criminal behaviour (Craig, 2007) . We set out to test whether this same functional variant shows association with psychopathy traits in adolescents with a history of childhood ADHD.
However, some findings have been negative. One potential reason for these inconsistencies is because samples vary in their exposure to environmental adversity as there have now been many published studies showing that the MAOA variant low-activity alleles increase the risk of antisocial behaviour only in the presence of early adversity (Caspi et al., 2002; Kim-Cohen et al., 2006; Taylor and Kim-Cohen, 2007; Thapar et al., 2007) . Our findings suggest another possibility, which needs to be tested, is that the link between the MAOA gene variant low-activity alleles and antisocial behaviour is because of associated psychopathy traits, specifically 'emotional dysfunction', although it is also conceivable that psychopathy traits in the context of ADHD have a distinct aetiology, and this also requires investigation. Overall, the evidence, to date, suggests that it is the low-activity alleles of the MAOA VNTR that are linked with antisocial, aggressive behaviour. This association seems to be most consistently evident in the presence of early adversity and our results suggest that there may also be a link with psychopathy traits (especially 'emotional dysfunction') in ADHD.
The serotonin transporter gene variant we examined is also functional. The short allele that was associated with psychopathy traits leads to lower activity of the transporter protein (Lesch et al., 1996) . The short allele (low activity) of the promoter variant (5HTTLPR) has been linked to CD (Sakai et al., 2006) , aggression, antisocial behaviour (Cadoret et al., 2003; Gerra et al., 2006; Haberstick et al., 2006) and antisocial personality disorder traits (Lyons-Ruth et al., 2007) , but again psychopathy traits have not been examined earlier. However, this short allele has also been linked to depression in the context of environmental adversity (Caspi et al., 2002; Zammit and Owen, 2006; Thapar et al., 2007) , especially in females. One possibility is that this allele has different effects depending on sex, environmental context and the presence of other genetic factors. We had very few females in our sample to detect sex differences and our results were not altered when females were excluded from the analysis.
Although the neurotransmitter serotonin has been reported to be linked with antisocial behaviour and especially impulsive, aggressive behaviour, analyses of central and peripheral serotonin (5HT) function studies have been conflicting (Blair et al., 2006) . Nonetheless, longitudinal studies of children have found links between serotonin dysfunction and aggression. In a recent longitudinal study of children with ADHD, lower serotonergic responsivity, assessed using hormonal response to fenfluramine, predicted the development of later antisocial personality disorder (Flory et al., 2007) . Our study findings further support the likely involvement of the serotonergic system in antisocial behaviour in ADHD, but the links in our sample are specifically with the 'emotional dysfunction' component of psychopathy traits. As already discussed, the functional polymorphisms in both MAOA (30-bp promoter region VNTR) and 5HTT (5HTTLPR) genes are associated with changes in transcriptional activity of these genes. Possession of low-activity alleles/genotypes in MAOA and 5HTT variants, in theory would both lead to increased synaptic levels of 5HT, and in our sample is associated with 'emotional dysfunction' scores. Our results are in this respect consistent with MAOA knockout mice studies, where elevated aggression is linked to increased 5HT (Cases et al., 1995) . However, MAOA is also involved in the breakdown of dopamine and noradrenaline. Given so little is known about the role of increased versus decreased levels of specific neurotransmitters in psychopathy (Glenn and Raine, 2008) , we are cautious in suggesting a single integrated biological theory with regard to psychopathy traits on the basis of our findings. Nevertheless, our results taken together with earlier human and animal work suggest that the MAOA and 5HTT functional variants we examined may contribute to different aspects of antisocial behaviour.
Finally, the functional variant we examined in the COMT gene has also been implicated earlier in antisocial behaviour. COMT is the main mechanism for clearing synaptic dopamine in the PFC and its activity is largely dictated by a Val 158 Met polymorphism. The highactivity Val/Val genotype is associated with increased PFC dopamine clearance and impaired PFC function (Tunbridge et al., 2006) . The same COMT genotype has been found to be associated with CD symptoms in ADHD in three of four published sets of data and in a pooled analysis (Thapar et al., 2005; Sengupta et al., 2006; Caspi et al., 2008) . Interestingly, in this follow-up study, we found additional links with the 'emotional dysfunction' but not total psychopathy trait scores. Moreover, the association with 'emotional dysfunction' was independent of the relationship with CD symptoms. These findings suggest that the COMT Val/Val genotype independently increases 'emotional dysfunction' scores and childhood CD symptoms in those with ADHD.
Overall, our findings support the premise that 'emotional dysfunction' scores or callous-unemotional traits, at least in ADHD, have biologically important correlates.
The functional gene variants that we selected on the basis of earlier reported associations with antisocial behaviour have also been examined in imaging studies of nonpatient samples (Canli and Lesch et al., 2007; Izquierdo et al., 2007) . Here, all the findings do not completely fit with the clinical literature in generating a consistent biological theory of psychopathy traits and antisocial behaviour. Specifically, MAOA low-activity allele carriers seem to show strong amygdale reactivity when presented with images of fearful and sad facial expressions . Similarly, the short (low-activity) alleles of the 5HTTLPR seem to be associated with increased amygdale activation in response to aversive stimuli (Heinz et al., 2005) , fearinducing pictures (Hariri et al., 2002) and increased stress reactivity (Gotlib et al., 2008) . In contrast, the COMT Val/Val genotype as well as affecting PFC function has been found to be associated with decreased limbic and prefrontal activation elicited by unpleasant stimuli . If higher psychopathy trait scores in our group are characterized by lower emotional reactivity (we do not know this), then our associated MAOA and 5HTT alleles and genotypes would be in the opposite direction and COMT genotype in the expected direction of what might be predicted on the basis of the imaging studies. There is no clear-cut explanation as to why this is the case. In contrast, the associated genotypes in our study are, however, consistent with those previously found to be associated with antisocial behaviour and we would expect this as antisocial behaviour, and psychopathy trait scores (total and emotional dysfunction) to show phenotypic correlation and share a common genetic liability (Baker et al., 2007; Larsson et al., 2007; Viding et al., 2007) . One possibility is that low emotional reactivity is not indexing psychopathy trait scores in our sample of children. This is a possibility given that in a recent UK study of children and adolescents, callousunemotional traits predicted emotional as well as behavioural symptoms (Moran et al., 2008) . Another possibility is that different, multiple biological pathways and brain mechanisms (Nelson and Jeste, 2008) , which are not necessarily emotion-based, could account for the link between gene variant and psychopathy trait measures as well as antisocial behaviour.
Limitations
There are a number of limitations to this study. The sample size was small and that could lead to false-positive and negative results. As for all genetic studies replication of findings is required, because of the possibility of chance associations, especially for the first published study. The effect size of each variant was small, but larger when the variants are considered together but these estimates will also be affected by the sample size. Our sample was also not large enough to use family-based tests of association.
Another consideration is generalizability. Our findings may only be applicable to those with ADHD and further work is warranted to determine whether this association also occurs in the general population and in those with clinically significant psychopathy. The biological mechanisms underlying psychopathy in those with ADHD that is recognized and treated could potentially be different to children with ADHD in the general population or those without ADHD. Larger samples will also be needed to stratify by individual exposure to environmental risk and test for gene-environment interaction. We also cannot draw conclusions about underlying biological and cognitive pathways. However, this is the first study, to the best of our knowledge, investigating the molecular genetic underpinnings of psychopathy and the positive findings provide a starting point for examining potential mechanisms.
In conclusion, this is the first study showing evidence of a specific relationship between functional gene variants in MAOA, 5HTT and COMT and psychopathic trait measures, specifically 'emotional dysfunction' scores in a high-risk ADHD group. These findings taken together with earlier research further implicate the involvement of serotonergic and dopaminergic function in antisocial behaviour through a relationship with psychopathy traits. Our results also suggest that the molecular genetic basis of psychopathic traits, at least in those with ADHD, is not necessarily explained by cooccurrence with CD. This, in conjunction, with other evidence highlights the importance of making the distinction between psychopathy/psychopathy traits and CD in young people, at least in those with ADHD. Our findings also suggest that although there is overlap between the 'emotional dysfunction' aspect and total psychopathy scores, the molecular genetic basis of these constructs does not seem to be identical.
